ABCL
AbCellera Biologics Inc. · Healthcare
CFO Andrew Booth sold $30.6M of AbCellera Biologics Inc.
Sold$30,600,000
$25.50Price
1,200,000Shares
−91%Stake
What ABCL did after the filing
- The stock from Thu, Jun 10 close, $24.84
- −36.4%
- S&P 500, same days
- +4.2%
Measured over 30 trading days, to the Jul 23 close.
Traded Wed, Jun 9. Filed Thu, Jun 10, 1:00 PM ET, during the session. Returns use the Jun 10 close and the Jul 23 close. Not investment advice.